Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Goodwill (2021 - 2025)

Historic Goodwill for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $1.1 billion.

  • Rxo's Goodwill fell 106.86% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 106.86%. This contributed to the annual value of $1.1 billion for FY2025, which is 106.86% down from last year.
  • Rxo's Goodwill amounted to $1.1 billion in Q4 2025, which was down 106.86% from $1.1 billion recorded in Q3 2025.
  • Rxo's 5-year Goodwill high stood at $1.1 billion for Q2 2025, and its period low was $630.0 million during Q4 2021.
  • Moreover, its 5-year median value for Goodwill was $630.0 million (2021), whereas its average is $820.2 million.
  • The largest annual percentage gain for Rxo's Goodwill in the last 5 years was 7857.14% (2025), contrasted with its biggest fall of 106.86% (2025).
  • Rxo's Goodwill (Quarter) stood at $630.0 million in 2021, then changed by 0.0% to $630.0 million in 2022, then changed by 0.0% to $630.0 million in 2023, then soared by 78.25% to $1.1 billion in 2024, then decreased by 1.07% to $1.1 billion in 2025.
  • Its Goodwill was $1.1 billion in Q4 2025, compared to $1.1 billion in Q3 2025 and $1.1 billion in Q2 2025.